EMA’s CHMP Starts Rolling Review of Inactivated COVID-19 Vaccine

The European Medicines Agency’s Committee for Medicinal Products for Human Use has started a rolling review of Vero Cell, an inactivated COVID-19 vaccine developed by Sinovac Life Sciences.